Home Home Home Inbox Home Search

Event

A Real World, Single Center Experience of Treatment of Severe Eosinophilic Asthma with IL-5 Antagonists; Mepolizumab and Reslizumab [Board No. P926]

Location: Board no. P926
Session Type: Thematic Poster Session
Sunday
May
20
11:15 AM
1:00 PM

Speaker(s)/Author(s)

Linda Rogers

MD
Icahn School of Medicine At Mount Sinai

Ruben Mylvaganam

MD
Icahn School of Medicine at Mount Sinai

View Abstract

A Real World, Single Center Experience of Treatment of Severe Eosinophilic Asthma with IL-5 Antagonists; Mepolizumab and Reslizumab

Parent Sessions

  • A35 - ASTHMA CLINICAL STUDIES II
    05-20-2018 9:15 AM - 4:15 PM
    • Home Home Home Inbox Home Search